U.S. Physical Therapy, Inc. (NYSE:USPH) Declares $0.44 Quarterly Dividend

U.S. Physical Therapy, Inc. (NYSE:USPH) announced a quarterly dividend on Tuesday, May 7th, Zacks reports. Stockholders of record on Thursday, May 23rd will be paid a dividend of 0.44 per share on Friday, June 14th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.68%. The ex-dividend date of this dividend is Wednesday, May 22nd.

U.S. Physical Therapy has raised its dividend by an average of 75.2% per year over the last three years and has raised its dividend annually for the last 5 consecutive years. U.S. Physical Therapy has a payout ratio of 57.0% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect U.S. Physical Therapy to earn $3.06 per share next year, which means the company should continue to be able to cover its $1.76 annual dividend with an expected future payout ratio of 57.5%.

U.S. Physical Therapy Stock Performance

Shares of USPH traded up $1.06 during trading hours on Thursday, reaching $104.98. 22,159 shares of the company traded hands, compared to its average volume of 68,791. U.S. Physical Therapy has a 12-month low of $78.08 and a 12-month high of $124.11. The company has a quick ratio of 2.28, a current ratio of 2.28 and a debt-to-equity ratio of 0.29. The stock has a market capitalization of $1.58 billion, a P/E ratio of 77.76, a P/E/G ratio of 4.99 and a beta of 1.39. The business has a fifty day moving average price of $105.34 and a 200-day moving average price of $96.37.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.51 EPS for the quarter, missing the consensus estimate of $0.58 by ($0.07). U.S. Physical Therapy had a net margin of 4.67% and a return on equity of 8.52%. The business had revenue of $155.70 million during the quarter, compared to analysts’ expectations of $153.30 million. During the same period in the previous year, the company posted $0.59 earnings per share. U.S. Physical Therapy’s revenue for the quarter was up 4.8% compared to the same quarter last year. Equities analysts anticipate that U.S. Physical Therapy will post 2.77 EPS for the current fiscal year.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 2,629 shares of the stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $104.39, for a total value of $274,441.31. Following the completion of the sale, the chief operating officer now owns 6,902 shares in the company, valued at approximately $720,499.78. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, COO Graham D. Reeve sold 2,629 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $104.39, for a total value of $274,441.31. Following the completion of the sale, the chief operating officer now owns 6,902 shares of the company’s stock, valued at approximately $720,499.78. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Carey P. Hendrickson sold 1,800 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total transaction of $193,104.00. Following the completion of the sale, the chief financial officer now directly owns 21,186 shares of the company’s stock, valued at approximately $2,272,834.08. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,829 shares of company stock worth $1,141,535. Insiders own 1.70% of the company’s stock.

Wall Street Analysts Forecast Growth

USPH has been the topic of several recent analyst reports. Barrington Research reissued an “outperform” rating and set a $122.00 target price on shares of U.S. Physical Therapy in a research note on Thursday. JPMorgan Chase & Co. upped their price target on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. Finally, StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $125.67.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.